Midland States Bancorp, Inc.
For the period ended Dec 31, 2024. Filed Jul 1, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jul 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
| Report of Independent Registered Public Accounting Firm (PCAOB ID 173) | 60 |
|---|---|
| Consolidated Balance Sheets | 61 |
| Consolidated Statements of Income | 62 |
| Consolidated Statements of Comprehensive Income | 63 |
| Consolidated Statements of Shareholders' Equity | 64 |
| Consolidated Statements of Cash Flows | 65 |
| Note 1. Summary of Significant Accounting Policies | 66 |
| Note 2. Investment Securities | 76 |
| Note 3. Loans | 78 |
| Note 4. Premises, Equipment and Leases | 94 |
| Note 5: Operating Leases - Lessor | 95 |
| Note 6. Loan Servicing Rights | 95 |
| Note 7. Goodwill and Intangible Assets | 96 |
| Note 8. Derivative Instruments | 97 |
| Note 9. Deposits | 100 |
| Note 10. FHLB Advances and Other Borrowings | 101 |
| Note 11. Subordinated Debt | 102 |
| Note 12. Trust Preferred Debentures | 102 |
| Note 13. Accumulated Other Comprehensive Income (Loss) | 104 |
| Note 14. Income Taxes | 105 |
| Note 15. Retirement Plans | 107 |
| Note 16. Share-Based Compensation | 109 |
| Note 17. Preferred Stock | 110 |
| Note 18. Earnings Per Common Share | 111 |
| Note 19. Capital Requirements | 111 |
| Note 20. Fair Value of Financial Instruments | 113 |
| Note 21. Commitments, Contingencies and Credit Risk | 117 |
| Note 22. Segment Information | 118 |
| Note 23. Revenue from Contracts with Customers | 121 |
| Note 24. Parent Company Only Financial Information | 122 |
| Note 25. Restatement of Prior Period Financial Statements | 124 |
| Note 26. Subsequent Events | 135 |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Shareholders and the Board of Directors of Midland States Bancorp, Inc.
Effingham, Illinois
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of Midland Sates Bancorp, Inc. (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). We also have audited the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework: (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, because of the effects of the material weaknesses discussed in the following paragraphs, the Company has not maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework: (2013) issued by COSO.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The following material weaknesses have been identified and included in management's report:
The Company did not design and maintain controls to assess the risk of material misstatement with contracts related to non-routine transactions.
The Company did not design and maintain an effective internal control activities for evaluating the accounting and financial reporting related to third-party credit enhancement contracts.
The Company did not design and maintain effective internal controls over loan data, including the activities performed by certain third-party service organizations that perform core lending functions. The loan data control deficiencies affect the allowance for credit losses, loan balances, accrued interest, interest income, servicing fees, and the fair value of the credit enhancement derivative.
We considered these material weaknesses identified above in determining the nature, timing, and extent of audit tests applied in our audit of the 2024 consolidated financial statements, and our opinion on Internal Control over Financial Reporting does not affect our opinion on the financial statements.
Restatement of Previously Issued Financial Statements
As discussed in Note 1 to the consolidated financial statements, the 2023 and 2022 consolidated financial statements have been restated to correct misstatements.
Basis for Opinions
The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Allowance for Credit Losses on Loans – Qualitative Factors
As described in Notes 1 and 3 to the consolidated financial statements, the Allowance for Credit Losses on Loans (“ACL”) represents the Company’s estimate of amounts that are not expected to be collected over the contractual life of the Company’s held for investment loan portfolio. The estimate of the ACL is based on historical experience, current conditions, and reasonable and supportable forecasts. As of December 31, 2024, the Company’s ACL was $111.2 million, and the provision for credit losses on loans was $119.3 million for the year then ended.
The Company measures expected credit losses by utilizing a probability of default, loss given default, and exposure at default model to estimate the quantitative component of the allowance for credit losses for loans. Management qualitatively adjusts the quantitative model results for risk factors that are not considered within the modeling process but are relevant in assessing the expected credit losses. These qualitative factors are based upon management judgment and current assessment as to the impact of risks related to actual and expected changes in economic and business conditions and developments that affect the collectability of the loan pools, changes in volume and severity of past due financial assets, the volume of non-accrual assets, and the volume and severity of adversely classified or graded assets, changes in the value of the underlying collateral for loans that are non-collateral dependent, and other internal and external factors.
We have identified auditing the qualitative factors as a critical audit matter as management’s determination of the qualitative factors is subjective and involves significant management judgments; and our audit procedures related to certain of the qualitative factors involved a high degree of auditor judgment and required significant audit effort, including the need to involve more experienced audit personnel.
The primary audit procedures we performed to address this critical audit matter included:
Tested the operating effectiveness of the Company’s controls over the:
Review over the appropriateness of the framework for the qualitative factors.
Completeness and accuracy of internal data used in the qualitative factors.
Review over the relevance and reliability of external data used in the qualitative factors.
Mathematical accuracy of the qualitative factors.
Substantive tests included:
Testing the completeness and accuracy of internal data and relevance and reliability of external data used in the qualitative factors
Assessing the appropriateness and reasonableness of the framework developed for the qualitative factors including evaluating management’s judgments as to which factors impacted the qualitative analysis for each portfolio segment.
Performing testing over the accuracy of inputs utilized in the calculation of qualitative factors for each portfolio segment.
Testing the mathematical accuracy of the calculation of the qualitative factors.
Goodwill Impairment Assessment
As described in Notes 1 and 7 to the consolidated financial statements, goodwill is the excess of the purchase price over the fair value of the net assets of the business acquired and is periodically evaluated for impairment. The Company’s goodwill balance was $161.9 million as of December 31, 2024, of which $157.2 million is allocated to the Company’s banking segment.
The Company tests for impairment at least annually or, more frequently, if an event occurs or circumstances change that indicate that the fair value of the reporting unit may be below its carrying amount (triggering event). The Company determined that a triggering event occurred and performed a quantitative assessment of goodwill for the Company’s bank reporting unit as of December 31, 2024. The Company engaged a third-party service provider in performing its quantitative impairment assessment. The Company's impairment assessment estimated fair value using an income approach that incorporated a discounted cash flow model that involves management assumptions based upon internal forecasts.
We identified the auditing of the impairment assessment of goodwill as of December 31, 2024 as a critical audit matter due to the significant management judgments related to determining the fair value of the reporting unit, which in turn led to a high degree of auditor judgment and subjectivity in evaluating the fair value of the reporting unit, specifically the significant assumptions related to the multi-year cash projections that rely on internal forecasts and the discount rate. In addition, we used auditor employed specialists to assist in evaluating the significant assumptions.
The primary audit procedures we performed to address this critical audit matter included:
Tested the operating effectiveness of the Company’s controls over the:
Review for completeness and accuracy of internal data and evaluation of the relevance and reliability of external data used in the impairment assessment.
Review of the reasonableness of the Company’s internal forecasts utilized in the impairment assessment.
Evaluation of the reasonableness of the valuation methodologies and the significant assumptions, including discount rate.
Substantive tests included:
Evaluating the reasonableness of the valuation methodologies used to determine the fair value of the reporting unit.
Testing the completeness and accuracy of internal data, and evaluating the relevance and reliability of external data.
Evaluating the reasonableness of the internal forecasts utilized in the impairment assessment.
Utilization of auditor employed specialists to assist with the evaluation of the appropriateness of the valuation methodologies, reasonableness of the discount rate, and overall reasonableness of the fair value of the reporting unit.
Credit Enhancements Contained Within Third-Party Agreements
The Company has agreements with third parties to originate and service consumer and commercial loans that are included in the Company’s loan portfolio as described in Notes 1 and 3 to the consolidated financial statements. As part of these programs, the third-party provider offered various credit enhancements with respect to loans originated under the programs, including contributions to reserve accounts, yield maintenance and certain other payments. The Company has determined that the borrower payments and credit enhancement payments under the programs should be accounted for on a separate unit of account or gross basis, with loan yields and interest income recorded at the gross borrower loan rate, and credit losses and associated provisions for credit losses recorded on a gross basis over the life of the loans, and with all credit enhancement payments accounted for separately as a credit enhancement derivative. As of December 31, 2024, the Company recorded a credit enhancement asset of $16.8 million, which represents the fair value of the credit enhancement derivative associated with the agreements related to loans recorded on the consolidated balance sheet as of the same date.
We identified auditing the accounting associated with the credit enhancement contained within the third-party agreements as a critical audit matter due to the nature and extent of audit effort required, including the need for individuals with specialized knowledge. Additionally, material weaknesses were identified by the Company related to the accounting and financial reporting associated with the credit enhancement contained within the third-party agreements and its impact on consolidated financial statements.
The primary procedure we performed to address this critical audit matter included engaging our internal specialists to evaluate the third-party agreements and the related accounting treatment.
Crowe LLP
We have served as the Company’s auditor since 2017.
Oakbrook Terrace, Illinois
July 1, 2025
CONSOLIDATED BALANCE SHEETS
| December 31,2024 | December 31, 2023(Restated) | |
|---|---|---|
| Assets | ||
| Cash and due from banks | $114,055 | $134,212 |
| Federal funds sold | 711 | 849 |
| Cash and cash equivalents | 114,766 | 135,061 |
| Investment securities available for sale, at fair value | 1,207,574 | 915,895 |
| Equity securities, at fair value | 4,792 | 4,501 |
| Loans | 5,167,574 | 6,103,592 |
| Allowance for credit losses on loans | (111,204) | (159,319) |
| Total loans, net | 5,056,370 | 5,944,273 |
| Loans held for sale | 344,947 | 3,811 |
| Premises and equipment, net | 85,710 | 82,814 |
| Other real estate owned | 4,941 | 9,112 |
| Nonmarketable equity securities | 33,723 | 43,421 |
| Accrued interest receivable | 25,329 | 34,133 |
| Loan servicing rights, at lower of cost or fair value | 17,842 | 20,253 |
| Goodwill | 161,904 | 161,904 |
| Other intangible assets, net | 12,100 | 16,108 |
| Company-owned life insurance | 211,168 | 203,485 |
| Credit enhancement asset | 16,804 | 15,389 |
| Other assets | 208,839 | 199,886 |
| Total assets | $7,506,809 | $7,790,046 |
| Liabilities and Shareholders’ Equity | ||
| Liabilities: | ||
| Deposits: | ||
| Noninterest-bearing demand deposits | $1,055,564 | $1,145,395 |
| Interest-bearing deposits | 5,141,679 | 5,164,134 |
| Total deposits | 6,197,243 | 6,309,529 |
| Short-term borrowings | 87,499 | 34,865 |
| Federal Home Loan Bank advances and other borrowings | 258,000 | 476,000 |
| Subordinated debt | 77,749 | 93,546 |
| Trust preferred debentures | 51,205 | 50,616 |
| Accrued interest payable and other liabilities | 124,266 | 110,377 |
| Total liabilities | 6,795,962 | 7,074,933 |
| Shareholders’ Equity: | ||
| Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at December 31, 2024 and 2023, respectively | 110,548 | 110,548 |
| Common stock, $0.01 par value; 40,000,000 shares authorized; 21,494,485 and 21,551,402 shares issued and outstanding at December 31, 2024 and 2023, respectively | 215 | 216 |
| Capital surplus | 434,346 | 435,463 |
| Retained earnings | 247,698 | 245,639 |
| Accumulated other comprehensive loss, net of tax | (81,960) | (76,753) |
| Total shareholders’ equity | 710,847 | 715,113 |
| Total liabilities and shareholders’ equity | $7,506,809 | $7,790,046 |
CONSOLIDATED STATEMENTS OF INCOME
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023(Restated) | 2022(Restated) | |
| Interest income: | |||
| Loans including fees: | |||
| Taxable | $365,892 | $378,333 | $285,577 |
| Tax exempt | 1,536 | 1,764 | 2,082 |
| Loans held for sale | 392 | 260 | 404 |
| Investment securities: | |||
| Taxable | 49,769 | 28,653 | 15,801 |
| Tax exempt | 1,511 | 1,349 | 2,746 |
| Nonmarketable equity securities | 3,070 | 2,819 | 2,198 |
| Federal funds sold and cash investments | 3,958 | 3,922 | 3,907 |
| Total interest income | 426,128 | 417,100 | 312,715 |
| Interest expense: | |||
| Deposits | 160,676 | 136,947 | 36,061 |
| Short-term borrowings | 1,960 | 68 | 104 |
| Federal Home Loan Bank advances and other borrowings | 16,495 | 20,709 | 9,335 |
| Subordinated debt | 5,271 | 5,266 | 7,495 |
| Trust preferred debentures | 5,380 | 5,289 | 3,025 |
| Total interest expense | 189,782 | 168,279 | 56,020 |
| Net interest income | 236,346 | 248,821 | 256,695 |
| Provision for credit losses: | |||
| Provision for credit losses on loans | 119,262 | 82,560 | 75,435 |
| Provision for credit losses on unfunded commitments | 1,070 | — | 1,550 |
| Recapture of other credit losses | — | — | (221) |
| Total provision for credit losses | 120,332 | 82,560 | 76,764 |
| Net interest income after provision for credit losses | 116,014 | 166,261 | 179,931 |
| Noninterest income: | |||
| Wealth management revenue | 28,697 | 25,572 | 25,708 |
| Service charges on deposit accounts | 13,154 | 11,990 | 10,237 |
| Interchange revenue | 13,955 | 14,302 | 13,879 |
| Residential mortgage banking revenue | 2,418 | 1,903 | 1,509 |
| Income on company-owned life insurance | 7,683 | 4,439 | 3,584 |
| Loss on sales of investment securities, net | (230) | (9,372) | (230) |
| Gain on termination of hedged interest rate swaps | — | — | 17,531 |
| Impairment on commercial mortgage servicing rights | — | — | (1,263) |
| Credit enhancement income | 60,998 | 48,194 | 69,976 |
| Other income | 12,066 | 17,756 | 8,936 |
| Total noninterest income | 138,741 | 114,784 | 149,867 |
| Noninterest expense: | |||
| Salaries and employee benefits | 93,639 | 93,438 | 90,305 |
| Occupancy and equipment | 16,785 | 15,986 | 14,842 |
| Data processing | 28,160 | 26,286 | 24,350 |
| FDIC insurance | 5,278 | 4,779 | 3,336 |
| Professional services | 7,822 | 7,049 | 6,907 |
| Marketing | 3,926 | 3,158 | 3,318 |
| Communications | 1,364 | 1,741 | 2,382 |
| Loan expense | 5,954 | 4,206 | 4,586 |
| Loan servicing fees | 12,864 | 19,181 | 22,750 |
| Amortization of intangible assets | 4,008 | 4,758 | 5,410 |
| Other real estate owned | 5,569 | 333 | 5,188 |
| Loss on mortgage servicing rights held for sale | — | — | 3,250 |
| Impairment on leased assets and surrendered assets | 7,858 | — | — |
| Other expense | 14,628 | 12,168 | 11,788 |
| Total noninterest expense | 207,855 | 193,083 | 198,412 |
| Income before income taxes | 46,900 | 87,962 | 131,386 |
| Income tax expense | 8,856 | 26,807 | 31,149 |
| Net income | 38,044 | 61,155 | 100,237 |
| Preferred dividends | 8,913 | 8,913 | 3,169 |
| Net income available to common shareholders | $29,131 | $52,242 | $97,068 |
| Per common share data: | |||
| Basic earnings per common share | $1.32 | $2.33 | $4.29 |
| Diluted earnings per common share | $1.32 | $2.33 | $4.28 |
| Weighted average common shares outstanding | 21,731,689 | 22,115,869 | 22,341,498 |
| Weighted average diluted common shares outstanding | 21,737,958 | 22,124,402 | 22,395,698 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(dollars in thousands)
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023(Restated) | 2022(Restated) | |
| Net income | $38,044 | $61,155 | $100,237 |
| Other comprehensive (loss) income: | |||
| Investment securities available for sale: | |||
| Unrealized losses that occurred during the period | (9,278) | (2,536) | (106,927) |
| Recapture of credit loss expense | — | — | (221) |
| Reclassification adjustment for realized net losses on sales of investment securities included in net income | 230 | 9,372 | 230 |
| Reclassification adjustment for gains on fair value hedges included in net income | (142) | — | — |
| Income tax effect | 1,677 | (1,845) | 28,876 |
| Change in investment securities available for sale, net of tax | (7,513) | 4,991 | (78,042) |
| Cash flow hedges: | |||
| Net unrealized derivative losses on cash flow hedges | (1,692) | (2,452) | 2,551 |
| Reclassification adjustment for net losses (gains) realized in net income | 4,891 | 5,264 | (17,644) |
| Income tax effect | (893) | (759) | 4,101 |
| Change in cash flow hedges, net of tax | 2,306 | 2,053 | (10,992) |
| Other comprehensive (loss) income, net of tax | (5,207) | 7,044 | (89,034) |
| Total comprehensive income | $32,837 | $68,199 | $11,203 |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
| Preferred stock | Commonstock | Capitalsurplus | Retainedearnings | Accumulatedothercomprehensiveincome (loss) | Totalshareholders'equity | |
|---|---|---|---|---|---|---|
| Balances, December 31, 2021 | $— | $221 | $445,907 | $212,472 | $5,237 | $663,837 |
| Prior period adjustment from restatement | — | — | — | (63,647) | — | (63,647) |
| Balances, January 1, 2022 (Restated) | — | 221 | 445,907 | 148,825 | 5,237 | 600,190 |
| Net income | — | — | — | 100,237 | — | 100,237 |
| Other comprehensive loss | — | — | — | — | (89,034) | (89,034) |
| Issuance of preferred stock, net of offering costs | 110,548 | — | — | — | — | 110,548 |
| Common dividends declared ($1.16 per share) | — | — | — | (25,923) | — | (25,923) |
| Preferred dividends | — | — | — | (3,169) | — | (3,169) |
| Common stock repurchased | — | (1) | (1,108) | — | — | (1,109) |
| Share-based compensation expense | — | — | 2,211 | — | — | 2,211 |
| Issuance of common stock under employee benefit plans | — | 2 | 2,186 | — | — | 2,188 |
| Balances, December 31, 2022 (Restated) | $110,548 | $222 | $449,196 | $219,970 | $(83,797) | $696,139 |
| Net income | — | — | — | 61,155 | — | 61,155 |
| Other comprehensive income | — | — | — | — | 7,044 | 7,044 |
| Common dividends declared ($1.20 per share) | — | — | — | (26,573) | — | (26,573) |
| Preferred dividends | — | — | — | (8,913) | — | (8,913) |
| Common stock repurchased | — | (8) | (17,890) | — | — | (17,898) |
| Share-based compensation expense | — | — | 2,489 | — | — | 2,489 |
| Issuance of common stock under employee benefit plans | — | 2 | 1,668 | — | — | 1,670 |
| Balances, December 31, 2023 (Restated) | $110,548 | $216 | $435,463 | $245,639 | $(76,753) | $715,113 |
| Net income | — | — | — | 38,044 | — | 38,044 |
| Other comprehensive loss | — | — | — | — | (5,207) | (5,207) |
| Common dividends declared ($1.24 per share) | — | — | — | (27,072) | — | (27,072) |
| Preferred dividends | — | — | — | (8,913) | — | (8,913) |
| Common stock repurchased | — | (2) | (5,473) | — | — | (5,475) |
| Share-based compensation expense | — | — | 3,031 | — | — | 3,031 |
| Issuance of common stock under employee benefit plans | — | 1 | 1,325 | — | — | 1,326 |
| Balances, December, 31, 2024 | $110,548 | $215 | $434,346 | $247,698 | $(81,960) | $710,847 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
| Years Ended December 31, | |||
|---|---|---|---|
| 2024 | 2023(Restated) | 2022(Restated) | |
| Cash flows from operating activities: | |||
| Net income | $38,044 | $61,155 | $100,237 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Provision for credit losses | 120,332 | 82,560 | 76,764 |
| Depreciation on premises and equipment | 4,993 | 4,778 | 4,842 |
| Amortization of intangible assets | 4,008 | 4,758 | 5,410 |
| Amortization of operating lease right-of-use asset | 1,657 | 1,635 | 1,831 |
| Amortization of loan servicing rights | 2,498 | 1,550 | 2,294 |
| Share-based compensation expense | 3,031 | 2,489 | 2,211 |
| Increase in cash surrender value of life insurance | (7,683) | (4,439) | (3,320) |
| Gain on proceeds from company-owned life insurance | — | — | (264) |
| Investment securities (accretion) amortization, net | (6,789) | (2,414) | 2,311 |
| Gain on termination of hedged interest rate swaps | — | — | (17,531) |
| Loss on sales of investment securities, net | 230 | 9,372 | 230 |
| Gain on repurchase of subordinated debt | (231) | (676) | — |
| (Gain) loss on sales of other real estate owned | (26) | (819) | 118 |
| Impairment on other real estate owned | 4,866 | — | 4,277 |
| Origination of loans held for sale | (81,077) | (58,953) | (134,612) |
| Proceeds from sales of loans and leases held for sale | 78,514 | 57,952 | 269,958 |
| Gain on sale of loans held for sale | (2,307) | (2,395) | (844) |
| Impairment on commercial mortgage servicing rights | — | — | 1,263 |
| Loss on mortgage servicing rights held for sale | — | — | 3,250 |
| Impairment on leased assets and surrendered assets | 7,858 | — | — |
| Net change in operating assets and liabilities: | |||
| Accrued interest receivable | 8,804 | (4,360) | (1,448) |
| Credit enhancement asset | (1,415) | (2,376) | (18,792) |
| Other assets | (16,783) | (24,038) | 1,213 |
| Accrued expenses and other liabilities | 18,022 | 27,579 | (13,579) |
| Net cash provided by operating activities | 176,546 | 153,358 | 285,819 |
| Cash flows from investing activities: | |||
| Purchases of investment securities available for sale | (605,169) | (412,799) | (192,349) |
| Proceeds from sales of investment securities available for sale | 74,116 | 191,733 | 136,403 |
| Maturities and payments on investment securities available for sale | 233,563 | 74,531 | 85,077 |
| Purchases of equity securities | (268) | (286) | (511) |
| Proceeds from sales of equity securities | — | 5,148 | — |
| Net decrease (increase) in loans | 346,883 | 72,877 | (1,216,352) |
| Proceeds from loans held for sale previously classified as portfolio loans | 84,283 | 40,899 | — |
| Purchases of premises and equipment | (6,901) | (8,731) | (3,470) |
| Proceeds from sale of premises and equipment | 37 | 104 | 175 |
| Purchases of nonmarketable equity securities | (172,057) | (239,597) | (24,787) |
| Proceeds from redemptions of nonmarketable equity securities | 181,755 | 242,377 | 14,927 |
| Proceeds from sales of other real estate owned | 466 | 7,547 | 1,453 |
| (Purchases of) proceeds from company-owned life insurance, net | — | (48,603) | 1,518 |
| Net cash acquired in acquisitions | — | — | 60,275 |
| Net cash provided by (used in) investing activities | 136,708 | (74,800) | (1,137,641) |
| Cash flows from financing activities: | |||
| Net (decrease) increase in deposits | (112,286) | (55,123) | 174,210 |
| Net increase (decrease) in short-term borrowings | 52,634 | (7,446) | (34,492) |
| Net (decrease) increase in short-term FHLB borrowings | (166,000) | (174,000) | 250,000 |
| Proceeds from long-term FHLB borrowings | 263,000 | 215,000 | — |
| Payments made on long-term FHLB borrowings and other borrowings | (315,000) | (25,000) | (100,171) |
| Payments made on subordinated debt | (15,763) | (5,845) | (40,000) |
| Proceeds from issuance of preferred stock | — | — | 110,548 |
| Cash dividends paid on preferred stock | (8,913) | (8,913) | (3,169) |
| Cash dividends paid on common stock | (27,072) | (26,573) | (25,923) |
| Common stock repurchased | (5,475) | (17,898) | (1,109) |
| Proceeds from issuance of common stock under employee benefit plans | 1,326 | 1,670 | 2,188 |
| Net cash (used in) provided by financing activities | (333,549) | (104,128) | 332,082 |
| Net decrease in cash and cash equivalents | (20,295) | (25,570) | (519,740) |
| Cash and cash equivalents: | |||
| Beginning of period | 135,061 | 160,631 | 680,371 |
| End of period | $114,766 | $135,061 | $160,631 |
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.